Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Sell
31
SLAB Quote, Financials, Valuation and Earnings
Last price:
$125.07
Seasonality move
:
5.25%
Day range:
$123.78 - $126.48
52-week range:
$94.00 - $154.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.88x
P/B ratio:
3.73x
Volume:
147.5K
Avg. volume:
293K
1-year change:
-6.09%
Market cap:
$4B
Revenue:
$782.3M
EPS (TTM):
-$7.40
Analysts' Opinion
-
Consensus RatingSilicon Laboratories has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $112.38, Silicon Laboratories has an estimated downside of -9.54% from its current price of $124.22.
-
Price Target UpsideAccording to analysts, the highest upside price target is $135.00 representing -100% upside increase from its current price of $124.22.
Fair Value
-
According to the consensus of 9 analysts, Silicon Laboratories has -9.54% downside to fair value with a price target of $112.38 per share.
SLAB vs. S&P 500
-
Over the past 5 trading days, Silicon Laboratories has overperformed the S&P 500 by 0.83% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Silicon Laboratories does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Silicon Laboratories revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Silicon Laboratories reported revenues of $166.4M.
Earnings Growth
-
Silicon Laboratories earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Silicon Laboratories reported earnings per share of -$0.88.
Enterprise value:
3.7B
EV / Invested capital:
--
Price / LTM sales:
7.88x
EV / EBIT:
--
EV / Revenue:
7.25x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-214.90x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$265.9M
Return On Assets:
-17.52%
Net Income Margin (TTM):
-46.93%
Return On Equity:
-20.4%
Return On Invested Capital:
-20.09%
Operating Margin:
-17.85%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $975.5M | $952.7M | $505M | $203.8M | $166.4M | |
| Gross Profit | $613.1M | $574M | $265.9M | $119M | $90.3M | |
| Operating Income | $97.8M | $73M | -$210M | $12.2M | -$29.7M | |
| EBITDA | $169.5M | $143.8M | -$147.5M | $28M | -$14.6M | |
| Diluted EPS | $1.70 | $1.82 | -$7.40 | $0.32 | -$0.88 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $937.6M | $2.9B | $1.6B | $773.5M | $614.1M | |
| Total Assets | $1.9B | $3.6B | $2.3B | $1.5B | $1.2B | |
| Current Liabilities | $151.1M | $458.4M | $205.7M | $165.1M | $118.3M | |
| Total Liabilities | $773M | $991.9M | $784.7M | $215.1M | $167.9M | |
| Total Equity | $1.2B | $2.6B | $1.6B | $1.3B | $1.1B | |
| Total Debt | $561.7M | $445.1M | $529.1M | $45M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$160.4M | -$35M | -$5.5M | -$33.4M | $31.6M | |
| Cash From Investing | $428.3M | $626.2M | $194.7M | $10.3M | $30.2M | |
| Cash From Financing | -$1.1B | -$914.5M | -$46M | -$51.8M | $423K | |
| Free Cash Flow | -$189.6M | -$60M | -$17M | -$38.5M | $29.4M | |
SLAB
Sector
Market Cap
$4B
$125.7M
Price % of 52-Week High
80.19%
68.28%
Dividend Yield
0%
0%
Shareholder Yield
--
0.97%
1-Year Price Total Return
-6.09%
-8.48%
Beta (5-Year)
1.168
0.922
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$126.33
200-day SMA
Buy
Level
$117.45
Bollinger Bands (100)
Buy
Level
105.06 - 120.8
Chaikin Money Flow
Buy
Level
2.4M
20-day SMA
Buy
Level
$123.85
Relative Strength Index (RSI14)
Buy
Level
54.54
ADX Line
Buy
Level
20.83
Williams %R
Neutral
Level
-71.3095
50-day SMA
Buy
Level
$114.71
MACD (12, 26)
Buy
Level
3.72
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
19.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (12.9662)
Buy
CA Score
(Annual)
Level (0.7183)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-4.2361)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Silicon Laboratories Inc Inc. develops semiconductors, software, and system solutions for the Internet Internet of Things, Things (IoT), Internet infrastructure, industrial control, consumer, and automotive markets. The company operates through one segment, in a single segment of mixed-signal analog intensive products. The Company groups its products as Industrial & Commercial or Home & Life The Industrial & Commercial category contributes majority of the revenue for the company Geographically, the company operates in the United States, China, Taiwan, and the Rest rest of the world.
Stock Forecast FAQ
In the current month, SLAB has received 2 Buy ratings 7 Hold ratings, and 0 Sell ratings. The SLAB average analyst price target in the past 3 months is $112.38.
-
Where Will Silicon Laboratories Stock Be In 1 Year?
According to analysts, the consensus estimate is that Silicon Laboratories share price will drop to $112.38 per share over the next 12 months.
-
What Do Analysts Say About Silicon Laboratories?
Analysts are divided on their view about Silicon Laboratories share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Silicon Laboratories is a Sell and believe this share price will rise from its current level to $75.00.
-
What Is Silicon Laboratories's Price Target?
The price target for Silicon Laboratories over the next 1-year time period is forecast to be $112.38 according to 9 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is SLAB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Silicon Laboratories is a Hold. 7 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of SLAB?
You can purchase shares of Silicon Laboratories via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Silicon Laboratories shares.
-
What Is The Silicon Laboratories Share Price Today?
Silicon Laboratories was last trading at $125.07 per share. This represents the most recent stock quote for Silicon Laboratories. Yesterday, Silicon Laboratories closed at $124.22 per share.
-
How To Buy Silicon Laboratories Stock Online?
In order to purchase Silicon Laboratories stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Why Is Adobe Stock Dropping?
Why is Adobe stock dropping? A combination of underwhelming fiscal…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 41x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
25
DRUG alert for Jan 2
Bright Minds Biosciences [DRUG] is up 13.55% over the past day.
Buy
56
QMCO alert for Jan 2
Quantum [QMCO] is up 0.83% over the past day.
Buy
78
BMA alert for Jan 2
Banco Macro SA [BMA] is up 12.94% over the past day.
